{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31983"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"106"}],"units":"Participants"}],"description":"Population PK analysis was performed using nonlinear mixed effect modeling. The estimated allometric function for VMEL was 1.12.","groups":[{"description":"The PK population included all participants who received at least one dose of nab-paclitaxel and had evaluable concentration data.","id":"OG000","title":"PK Population"}],"paramType":"NUMBER","populationDescription":"PK population: all participants who received at least one dose of nab-paclitaxel and had evaluable concentration data","reportingStatus":"POSTED","timeFrame":"Cycle 1 Day 1 (Participants ≥ 6 years: 1-2 minutes prior to the end of infusion [EOI], and 15 minutes, 1, 3, 5, 8, 24, 48, and 72 hours after the EOI. Participants < 6 years: 1-2 minutes prior to the EOI, and 15 minutes, 3, 5, and 24 hours after the EOI.)","title":"Phase 1 and 2 Population PK: Maximum Elimination Rate From the Central Compartment (VMEL)","type":"SECONDARY","unitOfMeasure":"μg/h"}